Harbor Healthcare Advises Long's Drugs LTC Pharmacy on Their Sale

Thomson, GA and Columbia, SC, October 2020 – Harbor Healthcare is pleased to announce the successful sale of Long’s Drugs (“Longs”) long-term care (LTC) pharmacy assets, owned by Kinderhook Industries. The transaction included two pharmacy locations serving Georgia and South Carolina. The pharmacies emphasize a patient-first priority with a focus on clinical excellence.

“In today’s competitive and challenging LTC marketplace, it’s imperative to pinpoint synergies that may exist in search of an ideal buyer. Thoroughly understanding the complex operations of a pharmacy, both internal and external, are pivotal to the optimization of enterprise value. We are very pleased to have helped facilitate an event that drives growth for the business and supports the customers and patients in receiving exceptional service.” Said Michael Cammeyer of Harbor Healthcare.

The pharmacies will continue their exceptional operations and serve patients in their respective regions, as additional locations for their new parent company that is rapidly growing nationwide.

About Longs Pharmacy
Headquartered in Columbia, South Carolina, Longs provides comprehensive pharmacy services across the United States. Longs offers tailored pharmacy solutions through 340B and other channels for Ryan White Clinics, Federally Qualified Health Centers, and STD Clinics.

About Harbor Healthcare
Harbor Healthcare is a boutique investment bank offering a variety of M&A advisory services to healthcare and pharmacy businesses since 1995. The company is the M&A leader in LTC pharmacy across the North American continent and has completed transactions spanning the middle market. The company provides custom tailored solutions to independent owners of long-term care, specialty, home infusion, compounding and retail pharmacies. The firm offers unparalleled regulatory expertise and maintains strong business relationships with strategic and private equity acquirers. For more information, please visit https://harborhealthcare.com.

Click Here for a Sample of Our M&A Transactions

Select Transactions

Author:

Mark Alford

Director & Strategic Advisor

619-535-9005

A much deserved yet overdue thank you for your continued help and support of me with the questions that I ask of you from time to time. I appreciate your patience and perseverance in ensuring that you find the right answer for me.
Jeffrey E. Feldberg
Choosing someone that could mentor me with all of the nuances of this type of business was important. I was very fortunate to find Mark who has been instrumental in helping me understand not only what needed to be done but also how to accomplish it in the most effective, efficient way.
Tammy Miller
Being a pharmacist himself and owning his own businesses provides Ira with unique insight when working on behalf of a pharmacy owner… While working on my behalf, I observed several of Ira’s personality characteristics which helped create and keep the deal together; these being: people skills, positive attitude, decisiveness, creativity and intellect. In addition, during the transaction Ira was able to gain the respect of our prospective buyers with his expertise and style…
Ronald A. Memo, RPh
Ira Cammeyer is not a “business broker”. He and his colleagues are deal makers. They maximize your position in the market and represent you 110%. The association does not stop after the deal is done. Belonging to the “Ira” family brings you opportunities in the future. In addition, Ira is there for you. His opinion and network is just a phone call away.
Stanley R. Goldenberg, RPh, FASCP
Michael worked tirelessly in establishing financials that would convert our private business records into the format required for evaluation by potential capital partners. We could not be more pleased by the results and will continue our relationship with Harbor Healthcare so that they can assist us in finding potential acquisition targets.
Ron Belville, RPh

Harbor Healthcare Advises Long’s Drugs LTC Pharmacy on Their Sale

Click Here for a Sample of Our M&A Transactions

Mark Alford